XML 47 R37.htm IDEA: XBRL DOCUMENT v3.25.1
Collaboration, License, and Other Agreements - Schedule of Contract Balances, Antibody Collaboration (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Disaggregation of Revenue [Line Items]    
Accounts receivable, net $ 5,561.0 $ 6,211.9
Sanofi Collaboration Agreement, Antibody    
Disaggregation of Revenue [Line Items]    
Accounts receivable, net 1,192.8 1,216.2
Deferred revenue $ 549.5 $ 571.7